Nasus Pharma Ltd (NSRX) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-19 | 6-K | — | SEC |
| 2026-08-17 | 6-K | — | SEC |
| 2026-07-28 | 6-K | — | SEC |
| 2026-06-09 | 6-K | — | SEC |
| 2026-03-25 | 6-K | — | SEC |
| 2026-03-16 | 6-K | — | SEC |
| 2026-03-06 | 6-K | — | SEC |
| 2026-03-04 | 6-K | — | SEC |
| 2026-02-24 | 6-K | — | SEC |
| 2026-02-13 | 6-K | — | SEC |
| 2026-02-12 | 6-K | — | SEC |
| 2026-01-29 | 6-K | — | SEC |
| 2026-01-20 | 6-K | — | SEC |
| 2025-12-29 | 6-K | — | SEC |
| 2025-12-22 | 6-K | — | SEC |
| 2025-11-20 | 6-K | — | SEC |
| 2025-11-18 | 6-K | — | SEC |
| 2025-11-03 | 6-K | — | SEC |
| 2025-10-08 | 6-K | — | SEC |
| 2025-09-30 | 6-K | — | SEC |
| 2025-09-05 | 6-K | — | SEC |
| 2025-08-14 | 6-K | — | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.